Core Laboratories NV
NYSE:CLB
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
14.11
24.49
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Core Laboratories NV
Wall Street
Price Targets
CLB Price Targets Summary
Core Laboratories NV
According to Wall Street analysts, the average 1-year price target for
CLB
is 19.67 USD
with a low forecast of 14.14 USD and a high forecast of 25.2 USD.
CLB Last Price Targets
Core Laboratories NV
The latest public price target was made on Jul 15, 2024 by
Luke Lemoine
from
Piper Sandler
,
who expects
CLB
stock to
rise by 1%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Luke Lemoine
Piper Sandler
|
17
USD
Upside 1% |
5 months ago
Jul 15, 2024
|
Core Laboratories price target lowered to $17 from $18 at Piper Sandler
TheFly
|
Unknown Analyst
Citigroup
|
26
USD
Upside 54% |
1 year ago
Feb 7, 2023
|
Citigroup Maintains Neutral on Core Laboratories, Raises Price Target to $26
Benzinga
|
Price Targets
Operating Income
Forecast
Operating Income Estimate
Core Laboratories NV
For the last 8 years the
compound annual growth rate for
Core Laboratories NV's operating income is
-14%.
The projected
CAGR
for the next 4 years is
10%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CLB's stock price target?
Price Target
19.67
USD
According to Wall Street analysts, the average 1-year price target for
CLB
is 19.67 USD
with a low forecast of 14.14 USD and a high forecast of 25.2 USD.
What is Core Laboratories NV's Revenue forecast?
Projected CAGR
4%
For the last 8 years the
compound annual growth rate for
Core Laboratories NV's revenue is
-5%.
The projected
CAGR
for the next 4 years is
4%.
What is Core Laboratories NV's Operating Income forecast?
Projected CAGR
10%
For the last 8 years the
compound annual growth rate for
Core Laboratories NV's operating income is
-14%.
The projected
CAGR
for the next 4 years is
10%.
What is Core Laboratories NV's Net Income forecast?
Projected CAGR
10%
For the last 8 years the
compound annual growth rate for
Core Laboratories NV's net income is
-13%.
The projected
CAGR
for the next 4 years is
10%.
You don't have any saved screeners yet
